Genmab A/S (OTCMKTS:GNMSF) Shares Cross Below Two Hundred Day Moving Average – Time to Sell?

Shares of Genmab A/S (OTCMKTS:GNMSF) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $266.48 and traded as low as $218.93. Genmab A/S shares last traded at $218.93, with a volume of 765 shares traded.

Genmab A/S Price Performance

The stock’s 50-day moving average price is $253.74 and its 200 day moving average price is $266.48. The firm has a market cap of $14.31 billion, a P/E ratio of 18.12 and a beta of 1.06.

Genmab A/S (OTCMKTS:GNMSF) last announced its quarterly earnings data on Thursday, August 8th. The company reported $3.13 EPS for the quarter. The business had revenue of $779.50 million for the quarter. Genmab A/S had a net margin of 29.06% and a return on equity of 20.60%.

Genmab A/S Company Profile

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.